Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IgY Antibodies in Egg Yolk for Helicobacter Pylori
NCT06973889Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Dec 2023
- Primary completion
- Dec 2024
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Helicobacter pylori infection (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Respiratory urea level at 8 weeks. Started Dec 2023; status: completed.
02
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT06973889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06973889.